Skip to content
Research Article Open access CC BY 4.0

Using Pazopanib and Radiotherapy to Treat Metastatic Renal Cell Carcinoma with Acrometastases

Cigdem Usul Afsar, Semra Paydas

International Journal of Medical and Pharmaceutical Case Reports · pp. 50–53 · Published 2 May 2015

10.9734/IJMPCR/2015/17236

Abstract

Introduction: Renal cell carcinoma (RCC) is the third most common urological cancer. Skeletal metastases from renal cell carcinoma are common, but metastatic tumors involving the hand and foot are rare. This is known as acrometastases and is usually a late manifestation ofdisseminated disease. Case: We present a metastatic case of RCC with acrometastases. Pazopanib treatment was started and there was a quick but short-term response. The patient refused to have surgery for hand lesions so radiotherapy was given. The patient is in good health and under pazopanib treatment. Conclusion: RCC patients with acral metastases have a short median survival and a choice of treatment should be made considering this poor prognosis. Surgery is the usual choice for treatment. However, if there are multiple digital metastases the quality of life of the patient should be taken into account. Palliative radiotherapy and pazopanib helped our patient and improved his quality of life.

Renal cell carcinoma pazopanib, acrometastases.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.